![Shao Lee Lin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shao Lee Lin
Verkställande Direktör på
CUE BIOPHARMA, INC.
Förmögenhet: 21 M $ per 2026-06-30
Profil
Shao Lee Lin was the founder of ACELYRIN, Inc., founded in 2020, serving as Chief Executive Officer & Director from 2020 to 2024.
Current jobs include President, Chief Executive Officer & Director at Cue Biopharma, Inc. since 2026, and Director at Surrozen Operating, Inc. since 2021.
Former jobs include Director at Principia Biopharma, Inc. from 2019 to 2020; Independent Director at Surrozen, Inc. from 2021 to 2026; Independent Director at Third Harmonic Bio, Inc. from 2020 to 2023; VP-Inflammation & Respiratory Development at Gilead Sciences, Inc. from 2012 to 2015; VP-Therapeutic Areas & Development Excellence at AbbVie, Inc. from 2015 to 2017; Chief Scientific Officer, EVP, Head-R&D at Horizon Therapeutics Ltd. (Ireland) from 2018 to 2020; and Trustee at Lake Forest College from 2018 to 2020.
Education includes undergraduate studies at William Marsh Rice University and a doctorate from The Johns Hopkins University School of Medicine.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 15,6 % | 2026-07-09 | 655 074 ( 15,6 % ) | 21 M $ | 2026-06-30 |
SURROZEN INC 0,02 % | 2025-05-14 | 2 341 ( 0,02 % ) | 60 749 $ | 2026-06-30 |
Aktiva positioner av Shao Lee Lin
| Företag | Position | Start |
|---|---|---|
| CUE BIOPHARMA, INC. | Verkställande Direktör | 2026-04-30 |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Direktör/Styrelseledamot | 2021-02-02 |
Tidigare kända positioner av Shao Lee Lin
| Företag | Position | Slut |
|---|---|---|
| SURROZEN, INC. | Direktör/Styrelseledamot | 2026-01-26 |
| ACELYRIN, INC. | Grundare | 2024-05-08 |
| THIRD HARMONIC BIO, INC. | Direktör/Styrelseledamot | 2023-01-17 |
| PRINCIPIA BIOPHARMA INC. | Direktör/Styrelseledamot | 2020-09-28 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Teknisk/Vetenskaplig/F&U Direktör | 2020-01-23 |
Shao Lee Lins utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
60
Första gradens relationer
12
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 12 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Rice University
 Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lake Forest College
 Lake Forest College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Health Technology |
Third Harmonic Bio, Inc.
 Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
ACELYRIN, Inc.
 ACELYRIN, Inc. Pharmaceuticals: MajorHealth Technology Operates as late-stage clinical biopharmaceutical company which focuses on identifying, acquiring and accelerating the development & commercialization of medicines | Health Technology |
Surrozen, Inc.
 Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates | Health Technology |
